cyclopentane has been researched along with Adenocarcinoma, Clear Cell in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashworth, A; Dexter, T; El-Bahrawy, M; Faratian, D; Fenwick, K; Gabra, H; Gao, Q; Geyer, FC; Gore, ME; Graham, A; Jameson, C; Kaye, SB; Lambros, MB; Lord, CJ; Mackay, A; MarchiĆ², C; McCluggage, WG; Natrajan, R; Paige, AJ; Parry, S; Rayter, S; Reis-Filho, JS; Savage, K; Tamber, N; Tan, DS; Vatcheva, R; Williams, A; Zvelebil, M | 1 |
1 other study(ies) available for cyclopentane and Adenocarcinoma, Clear Cell
Article | Year |
---|---|
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas.
Topics: Adenocarcinoma, Clear Cell; Cell Line, Tumor; Chromosome Aberrations; Chromosomes, Human, Pair 17; Comparative Genomic Hybridization; Cyclopentanes; Enzyme Inhibitors; Female; Gene Amplification; Gene Expression Profiling; Genes, p53; Humans; Mutation; Ovarian Neoplasms; p38 Mitogen-Activated Protein Kinases; Phosphoprotein Phosphatases; Protein Phosphatase 2C; RNA Interference; Thiophenes | 2009 |